HF004
In those patients with a current diagnosis of heart failure due to left ventricular systolic dysfunction who are currently treated with an ACE-I or ARB, the percentage of patients who are additionally currently treated with a beta- blocker licensed for heart failure for heart failure
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| HF 4 | 2011 | 440 | 533 | 82.5% | |
| HF 4 | 2012 | 499 | 587 | 85.0% | |
| HF 4 | 2013 | 548 | 625 | 87.7% | |
| HF004 | 2014 | 320 | 342 | 93.6% | |
| HF004 | 2015 | 354 | 374 | 94.7% | |
| HF004 | 2016 | 387 | 411 | 94.2% | |
| HF004 | 2017 | 409 | 435 | 94.0% | |
| HF004 | 2018 | 455 | 479 | 95.0% | |
| HF004 | 2019 | 627 | 668 | 93.9% | |
| HF004 | 2020 | 633 | 674 | 93.9% | |
| HF006 | 2021 | 819 | 887 | 92.3% | |
| HF006 | 2022 | 998 | 1051 | 95.0% | |
| HF006 | 2023 | 1208 | 1254 | 96.3% |
